AAAAI Poster Presentation ARS-1 (neffy® Nasal Spray) 2.0 mg Versus Epinephrine Injection Products: An Integrated Pharmacokinetic Analysis AAAAI 2023: Poster 14 AAAAI 2023: Full Poster 14 Manuscript Product is for Investigational Use; neffy is the proposed trade name, not yet FDA approved, and might change.
